Convexity Labs

FONR

Convexity Analyst · FONR
Holdlow confidenceTactical · no named thesis
Generated Jun 21, 2026

Analyst Note: FONAR Corporation (FONR)

Date: 2026-06-13 Current Price: $19.09

1. Structural Readiness

  • State: Context-only
  • Conservative Entry:
  • Extension:
  • Breakout Level:
  • ATR at Breakout:
  • Current ATR: 0.4% (Sub-threshold)
  • Pivot Strength:
  • Cap Bucket: Micro
  • Sector: Healthcare
  • Industry:

Setup Classification:

2. Thesis Layer

This is a TACTICAL, setup-led name. There is NO named secular thesis attached to FONR as of this date. The investment case must be judged strictly on the quality of the technical setup (which is currently absent) and the underlying business fundamentals. No macro or thematic thesis should be invented to support the position; the conviction must rest entirely on the company's operational execution and the eventual formation of a valid technical structure.

3. Business Overview

FONAR Corporation operates in the Healthcare sector, specifically within the design, manufacturing, and servicing of Magnetic Resonance Imaging (MRI) equipment, alongside a management services division.

  • Core Operations: The company designs, manufactures, sells, and services MRI scanners, including its proprietary "Upright®" MRI systems which allow for weight-bearing imaging (standing, sitting, bending). As of June 30, 2025, the company held 245 issued patents, having obtained four new patents in fiscal 2025.
  • Business Segments:
  • Medical Equipment: Manufacturing and selling MRI scanners.
  • Physician Management and Diagnostic Services: Through its wholly-owned subsidiary, Health Management Corporation of America (HMCA), FONAR provides comprehensive management services to diagnostic imaging facilities. This includes billing, collections, credentialing, IT procurement, HR, and office space provision.
  • Operational Footprint: As of June 30, 2025, HMCA managed 44 MRI scanners (26 in New York, 18 in Florida). The company directly owns and operates five facilities in Florida.
  • Financial Performance (Fiscal 2025):
  • HMCA revenues from MRI facilities increased to $95.4 million in fiscal 2025, up from $94.6 million in fiscal 2024.
  • Service and maintenance revenues from the external installed base were approximately $8.4 million in fiscal 2025, compared to $7.6 million in fiscal 2024.
  • Revenue recognition on scanner service contracts follows a straight-line method over the contract period (usually one year).
  • Management Expectations (Source: 2025-09-22 Filing):
  • Management expects to complete the installation of an additional high-field magnet in Lynbrook, NY, and a new location in Nassau County, NY, during fiscal 2026.
  • Management expects to complete the merger with FONAR, LLC (Parent) and FONAR Acquisition Sub, Inc. in the fourth fiscal quarter of 2026.

4. Archetype and Conviction

  • Archetype: Growth Leader (as per layer_a classification).
  • Fit Analysis: The company fits the "Growth Leader" archetype based on its expansion of the installed base (two additional high-field magnets installed in fiscal 2025) and the strategic expectation to add further capacity in fiscal 2026. The recurring revenue model from HMCA management fees and service contracts supports a compounder-like profile, though the scale remains micro-cap.
  • Conviction Stack:
  • Thesis Strength: Low (No named secular thesis; purely tactical).
  • Evidence Quality: Moderate. The evidence base (E1–E20) provides clear operational metrics and a defined merger timeline, but lacks recent financial guidance for the full fiscal 2026 year or post-merger pro-forma data.
  • Structural Quality: Low. The current ATR of 0.4% is sub-threshold, and no technical structure (coils, pivots) is defined. The setup is currently non-actionable.
  • Rerating Potential: Dependent on the successful completion of the merger in Q4 2026 and the expansion of the HMCA managed base.
  • Valuation Context: No specific valuation multiples or financial spine data (P/E, EV/EBITDA) are provided in the evidence block for 2026-06-13.

5. Invalidations, Strengths, and Gaps

  • What Would Strengthen:
  • Confirmation of the merger closing in Q4 2026 as expected.
  • Continued growth in HMCA revenues beyond the $95.4M fiscal 2025 baseline.
  • What Would Invalidate:
  • Failure to complete the merger by the end of fiscal 2026.
  • Significant decline in service revenues or scanner utilization.
  • Gaps in Evidence:
  • Volatility: Current ATR is sub-threshold (0.4%), making risk sizing difficult.
  • Financial Guidance: No specific revenue or earnings guidance for the remainder of fiscal 2026 or post-merger expectations is available in the provided evidence.
  • Merger Terms: Specific details on the merger consideration (cash vs. stock) or valuation are not detailed in the provided excerpts.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: low Key risks: 1) Failure to complete merger by end of fiscal 2026; 2) Lack of defined technical entry/stop levels; 3) Micro-cap liquidity constraints; 4) Sub-threshold volatility preventing position sizing. Sizing hint: N/A (No setup defined) Expected path: Management expects merger completion in Q4 2026 and installation of new magnets in NY during fiscal 2026; technical structure must form before capital deployment. Expected horizon: 6-12 months (aligned with merger timeline and fiscal 2026 completion)

Loading chart...
Exhibit 1: FONR daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for FONR.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for FONR.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: